Advances in Translational Research and Clinical Care in Pancreatic Cancer: Where Are We Headed?
While significant advances have been made in the treatment of many different solid tumors, pancreatic cancer remains a glaring exception. Overall 5-year survival rates for pancreatic cancer remain in the single digits. While newer chemotherapy regimens such as FOLFIRINOX and nab-paclitaxel/gemcitabi...
Gespeichert in:
| Hauptverfasser: | , , , , |
|---|---|
| Format: | Artigo |
| Sprache: | Inglês |
| Veröffentlicht: |
Wiley
2019-01-01
|
| Schriftenreihe: | Gastroenterology Research and Practice |
| Online-Zugang: | http://dx.doi.org/10.1155/2019/7690528 |
| Tags: |
Keine Tags, Fügen Sie das erste Tag hinzu!
|